A carregar...
Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study
AIMS: Sodium glucose co‐transporter‐2 inhibitors have been shown to reduce cardiovascular events and heart failure in type 2 diabetic (T2D) patients with high cardiovascular risk. Dipeptidyl peptidase‐4 inhibitors showed neutral effects and may increase risk of heart failure. We aimed to compare car...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533436/ https://ncbi.nlm.nih.gov/pubmed/30767253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13903 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|